UK Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in UK is expected to reach a projected revenue of US$ 229.9 million by 2030. A compound annual growth rate of 6% is expected of UK clinical trial supplies market from 2024 to 2030.
Revenue, 2023 (US$M)
$152.5
Forecast, 2030 (US$M)
$229.9
CAGR, 2024 - 2030
6%
Report Coverage
UK

UK clinical trial supplies market, 2018-2030 (US$M)

UK

UK clinical trial supplies market highlights

  • The UK clinical trial supplies market generated a revenue of USD 152.5 million in 2023 and is expected to reach USD 229.9 million by 2030.
  • The UK market is expected to grow at a CAGR of 6% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial supplies market data book summary

Market revenue in 2023USD 152.5 million
Market revenue in 2030USD 229.9 million
Growth rate6% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, UK accounted for 5.9% of the global clinical trial supplies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 228.0 million by 2030.

Phase iii was the largest segment with a revenue share of 53.57% in 2023. Horizon Databook has segmented the UK clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.


The UK is one of the major hubs for biopharmaceutical companies based in Europe, such as GlaxoSmithKline plc, AstraZeneca, & Novartis, and all the clinical trials being conducted across Europe have some part of their supply chain going through the UK.

Major clinical supplies service players such as DHL, PCI, Alamac, Fisher Clinical, and Catalent have distribution and packaging centers in the UK, which provide services across Europe.

Brexit can have a major impact on small Contract Research Organizations (CROs) and Contract Manufacturing and Packaging Organizations (CMOs and CPOs) based in the UK owing to uncertain regulatory changes related to supply chain.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website

UK clinical trial supplies market size, by phase, 2018-2030 (US$M)

UK Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)

UK clinical trial supplies market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more